Friday, May 12, 2017 News Recap HCV on the Rise in Boomers, Women and Children A new report from the CDC in the USA has found that HCV is concentrated among baby boomers and is increasing rapidly among new generations of Americans. In over just five years, the number of new hepatitis C virus infections reported to the CDC has nearly tripled, reaching a 15-year high. New hepatitis C virus infections are increasing most rapidly among young people, wi...
Thousands of Georgians have been cured of hepatitis C as a result of a giant experiment, in which the ex-Soviet nation tests the effectiveness of an aggressive public-health strategy. In the unprecedented project, all Georgians suffering from hepatitis C – an estimated 130,000 individuals – are being treated with expensive American medications free of charge. The program has entered its third year this May, and by 2020, Georgia hopes to be the first count
Close to 8% of the Georgian population is living with hepatitis C, an infection that can lead to serious liver problems, including cancer. Georgia, a country nestled against the Black Sea between Turkey and Russia with a population of 3.7 million, has since taken on a public health effort to help reduce its prevalence of hepatitis C (HCV for short) by 90% by 2020. To make it happen, the US Centers for Disease Control and Prevention is working with Geor
TBILISI - The Georgian Government has approved a National Strategy for the Elimination of Hepatitis C during a cabinet session on Tuesday. The new campaign will run until 2020 and aim to cure 90 per cent of the patients infected with the virus and treat 95 per cent of those who suffer from Hepatitis. The program was originally proposed in April 2015 as a way to eliminate the spread of the virus. According to Georgian Prime Minister Giorgi Kvirikashv
Eastern Europe's Republic of Georgia, with a population of 5 million - of which 7% has hepatitis C - has approximately 350,000 HCV+ people, similar to the number with the disease in Canada. The country, with minimal resources for fighting such an epidemic, has teamed up with the maker of SOVALDI and HARVONI to attempt to demonstrate that, with careful planning and using new hepatitis C drugs, hepatitis C can be eliminated. The company, Gilead, is providing